Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-428,380
Closed -$9.14M 218
2017
Q1
$9.14M Sell
428,380
-6,000
-1% -$126K 0.21% 105
2016
Q4
$8.55M Sell
434,380
-1,035
-0.2% -$18.8K 0.19% 102
2016
Q3
$7.64M Sell
435,415
-675
-0.2% -$11.7K 0.17% 105
2016
Q2
$6.74M Hold
436,090
0.14% 109
2016
Q1
$6.84M Buy
436,090
+2,220
+0.5% +$32.3K 0.14% 107
2015
Q4
$6.95M Hold
433,870
0.13% 111
2015
Q3
$6.72M Buy
433,870
+14,600
+3% +$232K 0.13% 105
2015
Q2
$6.88M Buy
419,270
+400
+0.1% +$6.99K 0.12% 119
2015
Q1
$7.67M Buy
418,870
+58,500
+16% +$1.03M 0.14% 115
2014
Q4
$6.51M Hold
360,370
0.13% 123
2014
Q3
$4.82M Buy
360,370
+100,120
+38% +$1.46M 0.11% 131
2014
Q2
$3.79M Buy
+260,250
New +$3.8M 0.09% 168

Other funds holding GNTX

Nicholas Company's GNTX Position: Q2 2017 in Review

Nicholas Company sold out of Gentex (GNTX) in Q2 2017, closing a stake of 428,380 shares — an estimated $9.14M sold.

Nicholas Company first reported a position in GNTX in Q2 2014 and held it in 12 quarters. The position peaked at $9.14M in Q1 2017. 419 funds tracked by Wall St. Rank hold GNTX as of Q2 2017.

  • Nicholas Company reported no remaining Gentex position as of Q2 2017 after selling out during the quarter.
  • Nicholas Company sold 428,380 Gentex shares in Q2 2017, an estimated $9.14M.
  • Nicholas Company first reported a position in Gentex in Q2 2014 and held it in 12 quarters.
  • Nicholas Company's Gentex position peaked at $9.14M in Q1 2017.
  • 419 funds tracked by Wall St. Rank held Gentex as of Q2 2017.

Based on Nicholas Company's 13F filing for Q2 2017, filed 11 Aug 2017.